Skip to main content
Log in

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis

  • Pharmacometrics
  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The influence of the choice of pharmacokinetic model on subsequent determination of covariate relationships in population pharmacokinetic analysis was studied using both simulated and real data sets. Simulations and data analysis were both performed with the program NONMEM. Data were simulated using a two-compartment model, but at late sample times, so that preferential selection of the two-compartment model should have been impossible. A simple categorical covariate acting on clearance was included. Initially, on the basis of a difference in the objective function values, the two-compartment model was selected over the one-compartment model. Only when the complexity of the one-compartment model was increased in terms of the covariate and statistical models was the difference in objective function values of the two structural models negligible. For two real data sets, with which the two-compartment model was not selected preferentially, more complex covariate relationships were supported with the one-compartment model than with the two-compartment model. Thus, the choice of structural model can be affected as much by the covariate model as can the choice of covariate model be affected by the structural model; the two choices are interestingly intertwined. A suggestion on how to proceed when building population pharmacokinetic models is given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. L. Beal and L. B. Sheiner (eds.)NONMEM Users Guides, NONMEM Project Group, University of California, San Francisco, 1992.

    Google Scholar 

  2. L. B. Sheiner, B. Rosenberg, and K. L. Melmon. Modelling of individual pharmacokinetics for computer-aided drug dosage.Comp. Biomed. Res. 5:441–459 (1972).

    Article  Google Scholar 

  3. L. Aarons, S. Vozeh, M. Wenk, P. Weiss, and F. Follath. Population pharmacokinetics of tobramycin.Br. J. Clin. Pharmacol. 28:305–314 (1989).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. J. Antal, T. H. Grasela, and R. B. Smith. An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly.Clin. Pharmacol. Ther. 46:552–559 (1989).

    Article  CAS  PubMed  Google Scholar 

  5. L. Collart, T. F. Blaschke, F. Boucher, and C. G. Prober. Potential of population pharmacokinetics to reduce the frequency of blood sampling required for estimating kinetic parameters in neonates.Dev. Pharmacol. Ther. 18:71–80 (1992).

    CAS  PubMed  Google Scholar 

  6. K. Fattinger, S. Vozeh, A. Olafsson, J. Vlcek, M. Wenk and F. Follath. Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations.Clin. Pharmacol. Ther. 50:55–65 (1991).

    Article  CAS  PubMed  Google Scholar 

  7. K. Fattinger, S. Vozeh, H. R. Ha, M. Borner, and F. Follath. Population pharmacokinetics of quinidine.Br. J. Clin. Pharmacol. 31:279–286 (1991).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. H. Fluhler, H. Huber, E. Widmer, and S. Brechbuhler. Experiences in the application of NONMEM to pharmacokinetic data analysis.Drug Met. Rev. 15:317–339 (1984).

    Article  CAS  Google Scholar 

  9. S. R. Gitterman, G. L. Drusano, M. J. Egorin, H. C. Standiford, and the Veterans Administration Cooperative Studies Group. Population pharmacokinetics of zidovudine.Clin. Pharmacol. Ther. 48:161–167 (1990).

    Article  CAS  PubMed  Google Scholar 

  10. T. H. Grasela, E. J. Antal, R. J. Townsend, and R. B. Smith. An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodology.Clin. Pharmacol. Ther. 39:605–612 (1986).

    Article  PubMed  Google Scholar 

  11. T. H. Grasela, E. J. Antal, L. Ereshefsky, B. G. Wells, R. L. Evans, and R. B. Smith. An evaluation of population pharmacokinetics in therapeutic trials. Part, II. Detection of a drug-drug interaction.Clin. Pharmacol. Ther. 42:433–441 (1987).

    Article  PubMed  Google Scholar 

  12. D. A. Graves and I. Chang. Application of NONMEM to routine bioavailability data.J. Pharmacokin. Biopharm. 18:145–160 (1990).

    Article  CAS  Google Scholar 

  13. N. M. Graves, T. M. Ludden, G. B. Holmes, R. H. Fuerst, and I. E. Leppik. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modelling to clinical trials.Pharmacotherapy 9:372–376 (1989).

    CAS  PubMed  Google Scholar 

  14. J. Grevel, B. Whiting, A. W. Kelman, W. B. Taylor, and D. N. Bateman. Population analysis of the pharmacokinetic variability of high-dose metoclopramide in cancer patients.Clin. Pharmacokin. 14:52–63 (1988).

    Article  CAS  Google Scholar 

  15. J. Grevel, P. Thomas, and B. Whiting. Population pharmacokinetic analysis of bisoprolol.Clin. Pharmacokin. 17:53–63 (1989).

    Article  CAS  Google Scholar 

  16. M. Izquierdo, J. M. Lanao, L. Cervero, N. V. Jiminez, and A. Dominguez-Gil. Population pharmacokinetics of gentamicin in premature infants.Ther. Drug Monit. 14:177–183 (1992).

    Article  CAS  PubMed  Google Scholar 

  17. P. D. Jensen, B. E. Edgren, and R. C. Brundage. Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model.Pharmacotherapy 12:178–182 (1992).

    CAS  PubMed  Google Scholar 

  18. D. M. Jermain, M. L. Crismon, and E. S. Martin III Population pharmacokinetics of lithium.Clin. Pharm. 10:376–381 (1991).

    CAS  PubMed  Google Scholar 

  19. M. C. Launay, A. Iliadis, and B. Richard. Population pharmacokinetics of mitoxantrone performed by a NONMEM method.J. Pharm. Sci. 78:877–880 (1989).

    Article  CAS  PubMed  Google Scholar 

  20. E. S. Martin III, M. L. Crismon, and P. J. Godley. Postinduction carbamazepine clearance in an adult psychiatric population.Pharmacotherapy 11:296–302 (1991).

    PubMed  Google Scholar 

  21. S. M. Pai, U. A. Shukla, T. H. Grasela, C. A. Knupp, R. Dolin, F. T. Valentine, C. McLaren, H. A. Lieberman, R. R. Martin, K. A. Pittman, and R. H. Barbhaiya. Population pharmacokinetic analysis of Didanosine (2′, 3′-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex.J. Clin. Pharmacol. 32:242–247 (1992).

    Article  CAS  PubMed  Google Scholar 

  22. L. B. Sheiner, B. Rosenberg, and V. V. Marathe. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.J. Pharmacokin. Biopharm. 5:445–479 (1977).

    Article  CAS  Google Scholar 

  23. D. R. Stanski, and P. O. Maitre. Population pharmacokinetics and pharmacodynamics of thiopental: The effect of age revisited.Anaesthesiology 72:412–422 (1990).

    Article  CAS  Google Scholar 

  24. M. Tamayo, M. M. Fernandez de Gatta, M. J. Garcia, and A. Dominguez-Gil. Population pharmacokinetics of imipramine in children.Eur. J. Clin. Pharmacol. 43:89–92 (1992).

    Article  CAS  PubMed  Google Scholar 

  25. C. N. Verme, T. M. Ludden, W. A. Clementi, and S. C. Harris. Pharmacokinetics of quinidine in male patients: a population analysis.Clin. Pharmacokin. 22:468–480 (1992). and Erratum,Clin. Pharmacokin. 23:68 (1982).

    Article  CAS  Google Scholar 

  26. S. Vozeh, M. Wenk, and F. Follath. 2. Experience with NONMEM: analysis of serum concentration data in patients treated with mexiletine and lidocaine.Drug Met. Rev. 15:305–315 (1984).

    Article  CAS  Google Scholar 

  27. J. R. Wade, A. W. Kelman, D. J. Kerr, J. Robert, and B. Whiting. Variability in the pharmacokinetics of epirubicin: a population analysis.Cancer Chemother. Pharmacol. 29:391–395 (1992).

    Article  CAS  PubMed  Google Scholar 

  28. D. B. Wiest, J. B. Pinson, P. S. Gal, R. C. Brundage, S. Schall, J. L. Ransom, R. L. Weaver, D. Purohit, and Y. Brown. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus.Clin. Pharmacol. Ther. 49:550–557 (1991).

    Article  CAS  PubMed  Google Scholar 

  29. P. J. Williams, J. Lane, W. Murray, M. A. Mergener, and M. Kamigaki. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.Clin. Pharmacokin. 22:66–74 (1992).

    Article  CAS  Google Scholar 

  30. E. Yukawa, S. Higuchi, and T. Aoyama. Phenobarbitone population pharmacokinetics from routine clinical data: role of patient, characteristics for estimating dosage regimens.J. Pharm. Pharmacol. 44:755–760 (1992).

    Article  CAS  PubMed  Google Scholar 

  31. E. Yukawa, H. Mine, S. Higuchi, and T. Aoyama. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosage regimens.J. Pharm. Pharmacol. 44:761–765 (1992).

    Article  CAS  PubMed  Google Scholar 

  32. G. J. Yuen, G. L. Drusano, J. Brooks, and S. Flor. Use of nonlinear, mixed-effects modelling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.Pharmacotherapy 12:88–92 (1992).

    CAS  PubMed  Google Scholar 

  33. M. Rowland and T. N. Tozer.Clinical Pharmacokinetics: Concepts and Applications, 2nd ed., Lea and Fabiger, Philadelphia, PA, 1989, p. 447.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by National Institutes of Health grants GM 26691 and GM 26676

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wade, J.R., Beal, S.L. & Sambol, N.C. Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis. Journal of Pharmacokinetics and Biopharmaceutics 22, 165–177 (1994). https://doi.org/10.1007/BF02353542

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02353542

Key words

Navigation